Simulation of the hydrological impacts of climate change on a restored floodplain

Thirty UK Climate Projections 2009 (UKCP09) scenarios are simulated using a MIKE SHE/MIKE 11 model of a restored floodplain in eastern England. Annual precipitation exhibits uncertainty in direction of change. Extreme changes (10 and 90% probability) range between −27 and +30%. The central probability projects small declines ( < −4%). Wetter winters and drier summers predominate. Potential evapotranspiration increases for most scenarios (annual range of change: −41 to +2%). Declines in mean discharge predominate (range: −41 to +25%). Reductions of 11–17% are projected for the central probability. High and low flows, and the frequency of bankfull discharge exceedence reduce in most cases. Duration of winter high floodplain water tables declines. Summer water tables are on average at least 0.11 and 0.18 m lower for the 2050s and 2080s, respectively. Flood extent declines in most scenarios. Drier conditions will likely induce ecological responses including impacts on floodplain vegetation

Clonal hematopoiesis associated with epigenetic aging and clinical outcomes

Clonal hematopoiesis of indeterminate potential (CHIP) is a common precursor state for blood cancers that most frequently occurs due to mutations in the DNA-methylation modifying enzymes DNMT3A or TET2. We used DNA-methylation array and whole-genome sequencing data from four cohorts together comprising 5522 persons to study the association between CHIP, epigenetic clocks, and health outcomes. CHIP was strongly associated with epigenetic age acceleration, defined as the residual after regressing epigenetic clock age on chronological age, in several clocks, ranging from 1.31 years (GrimAge, p &lt; 8.6 × 10−7) to 3.08 years (EEAA, p &lt; 3.7 × 10−18). Mutations in most CHIP genes except DNA-damage response genes were associated with increases in several measures of age acceleration. CHIP carriers with mutations in multiple genes had the largest increases in age acceleration and decrease in estimated telomere length. Finally, we found that ~40% of CHIP carriers had acceleration &gt;0 in both Hannum and GrimAge (referred to as AgeAccelHG+). This group was at high risk of all-cause mortality (hazard ratio 2.90, p &lt; 4.1 × 10−8) and coronary heart disease (CHD) (hazard ratio 3.24, p &lt; 9.3 × 10−6) compared to those who were CHIP−/AgeAccelHG−. In contrast, the other ~60% of CHIP carriers who were AgeAccelHG− were not at increased risk of these outcomes. In summary, CHIP is strongly linked to age acceleration in multiple clocks, and the combination of CHIP and epigenetic aging may be used to identify a population at high risk for adverse outcomes and who may be a target for clinical interventions

Implementing precision methods in personalizing psychological therapies: barriers and possible ways forward

This is the final version. Available on open access from Elsevier via the DOI in this recordData availability: No data was used for the research described in the article.Highlights: • Personalizing psychological treatments means to customize treatment for individuals to enhance outcomes. • The application of precision methods to clinical psychology has led to data-driven psychological therapies. • Applying data-informed psychological therapies involves clinical, technical, statistical, and contextual aspects